CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 186 filers reported holding CHEMOCENTRYX INC in Q1 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $59,250,000 | +137.5% | 1,146,933 | +13.9% | 0.01% | +125.0% |
| Q2 2022 | $24,951,000 | -0.5% | 1,006,934 | +0.7% | 0.00% | +33.3% |
| Q1 2022 | $25,080,000 | -26.1% | 1,000,415 | +7.3% | 0.00% | -25.0% |
| Q4 2021 | $33,940,000 | +112.2% | 932,169 | -0.3% | 0.00% | +100.0% |
| Q3 2021 | $15,995,000 | +32.9% | 935,419 | +4.1% | 0.00% | 0.0% |
| Q2 2021 | $12,034,000 | -72.5% | 898,738 | +5.2% | 0.00% | -71.4% |
| Q1 2021 | $43,754,000 | -11.1% | 853,910 | +7.4% | 0.01% | -12.5% |
| Q4 2020 | $49,221,000 | +20.1% | 794,918 | +6.3% | 0.01% | 0.0% |
| Q3 2020 | $40,996,000 | +0.5% | 748,109 | +5.5% | 0.01% | -11.1% |
| Q2 2020 | $40,786,000 | +60.0% | 708,831 | +11.7% | 0.01% | +28.6% |
| Q1 2020 | $25,495,000 | -43.8% | 634,532 | -44.7% | 0.01% | +40.0% |
| Q4 2019 | $45,368,000 | +1195.9% | 1,147,106 | +122.1% | 0.01% | +400.0% |
| Q3 2019 | $3,501,000 | -30.1% | 516,473 | -4.2% | 0.00% | 0.0% |
| Q2 2019 | $5,012,000 | 0.0% | 539,012 | +49.3% | 0.00% | 0.0% |
| Q1 2019 | $5,012,000 | -31.2% | 360,931 | -46.0% | 0.00% | 0.0% |
| Q4 2018 | $7,284,000 | +129.6% | 667,834 | +166.1% | 0.00% | 0.0% |
| Q3 2018 | $3,172,000 | +3.5% | 250,999 | +7.9% | 0.00% | 0.0% |
| Q2 2018 | $3,064,000 | -13.2% | 232,728 | -10.3% | 0.00% | 0.0% |
| Q1 2018 | $3,529,000 | +149.4% | 259,558 | +9.1% | 0.00% | – |
| Q4 2017 | $1,415,000 | -21.1% | 237,952 | -1.6% | 0.00% | -100.0% |
| Q3 2017 | $1,794,000 | -4.4% | 241,907 | +20.7% | 0.00% | 0.0% |
| Q2 2017 | $1,876,000 | +31.0% | 200,470 | +1.9% | 0.00% | 0.0% |
| Q1 2017 | $1,432,000 | +2.9% | 196,708 | +4.6% | 0.00% | 0.0% |
| Q4 2016 | $1,391,000 | +50.7% | 188,011 | +22.9% | 0.00% | – |
| Q3 2016 | $923,000 | +39.0% | 152,943 | +3.4% | 0.00% | – |
| Q2 2016 | $664,000 | +74.3% | 147,922 | -3.4% | 0.00% | – |
| Q1 2016 | $381,000 | -69.5% | 153,186 | -0.8% | 0.00% | -100.0% |
| Q4 2015 | $1,250,000 | +42.2% | 154,465 | +6.3% | 0.00% | 0.0% |
| Q3 2015 | $879,000 | -25.4% | 145,346 | +1.4% | 0.00% | 0.0% |
| Q2 2015 | $1,179,000 | +11.8% | 143,272 | +2.5% | 0.00% | 0.0% |
| Q1 2015 | $1,055,000 | +19.8% | 139,744 | +8.3% | 0.00% | 0.0% |
| Q4 2014 | $881,000 | +54.6% | 129,041 | +1.8% | 0.00% | – |
| Q3 2014 | $570,000 | -20.8% | 126,785 | +2.9% | 0.00% | – |
| Q2 2014 | $720,000 | -9.3% | 123,204 | +2.8% | 0.00% | -100.0% |
| Q1 2014 | $794,000 | +56.6% | 119,873 | +36.7% | 0.00% | – |
| Q4 2013 | $507,000 | +5.8% | 87,670 | +1.7% | 0.00% | – |
| Q3 2013 | $479,000 | -59.0% | 86,214 | +4.3% | 0.00% | -100.0% |
| Q2 2013 | $1,169,000 | – | 82,675 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |